The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm

Status Completed

Clinical Trial Summary

The trial was designed to assess the effect of daily dose of 300 mg omega-3 supplements for 2 months on the selected interleukins levels in uninfected people with Covid-19.

Clinical Trial Description

Omega-3 Fatty Acids (Omega-3) are long poly unsaturated fatty acids that can be found in plants and fish, its refer to a group composed of three type of fatty acids called: Eicosapentaenoic acid (EPA), Alpha-linoleic acid (ALA), and Docosahexaenoic acid (DHA) . The health promoting effect of n-3FA may be due to immune modulating and anti-inflammatory actions . The anti-inflammatory properties of n-3FA are used for treatment of the inflammatory diseases such as irritable bowel syndrome, rheumatoid arthritis, eczema, and psoriasis . Many studies reported a significant reduction in the risk of cancers in breast, prostate, ovaries with supplementation of n-3FA (Larsson et al. 2004) .However, high-doses omega-3 supplements such as 1000 mg/day are widely spread in community pharmacies in Jordan . Currently , community pharmacy around the world are facing the challenge of increased demand for care of uninfected people with Covid -19. Accordingly , the current randomized clinical trial was designed to evaluate the effect of daily 300 mg of omega 3-FA supplements on the immune health status of uninfected people with Covid-19 as a part of as a part of preventive health care . Therefore , this RCT aims to assess whether regular daily dose of regular daily dose of omega 3-FA (300 mg) for 2 months supplementation against COVID-19 infection as a part of preventive treatment protocol in uninfected Jordanian peoples. The investigators hypothesize that the regular dose of omega 3-FA (300 mg) /day for 2 months will significantly change immune responses compared with the control group. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04483271
Study type	Interventional
Source	Applied Science Private University
Contact
Status	Completed
Phase	N/A
Start date	October 2, 2020
Completion date	February 28, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03685383` - Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation	N/A
Recruiting	`NCT05491304` - Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis	Phase 4
Suspended	`NCT04385771` - Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation	N/A
Completed	`NCT05307601` - Immune Response Following COVID-19 in Hemodialysis Patients
Completed	`NCT04476745` - The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People	N/A
Completed	`NCT04798677` - Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine	N/A
Completed	`NCT01302223` - Keratinocyte Growth Factor and Cytokines in Burns.	N/A
Not yet recruiting	`NCT05013034` - Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients	Phase 2
Completed	`NCT04910893` - Cytokine Adsorption in Severe, Refractory Septic Shock	N/A
Completed	`NCT04854252` - Inflammatory Response to Opioid Versus Opioid Free Anesthesia	N/A
Completed	`NCT04366908` - Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome	Phase 2
Terminated	`NCT04415073` - A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19	Phase 2
Completed	`NCT04377308` - Fluoxetine to Reduce Intubation and Death After COVID19 Infection	Phase 4
Completed	`NCT04324528` - Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation	N/A
Completed	`NCT05476848` - Relationship Between Oral Findings and Salivary Factors in Sars-Cov-2 Patients	N/A
Completed	`NCT04913298` - Prospective Study for the Application of Cytosorb® in Critically Ill Patients	N/A
Recruiting	`NCT04753476` - Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia	Phase 2
Terminated	`NCT04327505` - Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19	Phase 2/Phase 3
Withdrawn	`NCT04433078` - RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM	Phase 2
Completed	`NCT04901338` - Cytokine Hemoadsorption in ECMO Patients